THR | TKR | |||||
---|---|---|---|---|---|---|
Measure | Baseline | Follow-up | p-value | Baseline | Follow-up | p-value |
n | 75 | 75 | 69 | 69 | ||
EQ-5D-5L utility index (median [IQR]) | 0.48 [0.33, 0.77] | 0.88 [0.76, 0.94] | < 0.001b | 0.67 [0.46, 0.85] | 0.88 [0.74, 0.94] | < 0.001b |
EQ-VAS (mean (SD)) | 56.80 (21.95) | 69.44 (21.65) | < 0.001a | 60.64 (19.81) | 71.04 (18.82) | 0.002a |
WOMAC global (mean (SD)) | 41.93 (17.94) | 74.22 (18.45) | < 0.001a | 54.36 (19.90) | 70.46 (19.05) | < 0.001a |
WOMAC functioning (mean (SD)) | 42.90 (18.52) | 76.02 (19.99) | < 0.001a | 58.55 (20.20) | 74.10 (20.16) | < 0.001a |
WOMAC pain (mean (SD)) | 44.40 (19.85) | 80.82 (18.83) | < 0.001a | 53.62 (21.28) | 74.24 (18.02) | < 0.001a |
WOMAC stiffness (mean (SD)) | 38.50 (24.64) | 65.83 (23.01) | < 0.001a | 50.91 (27.06) | 63.04 (24.86) | 0.007a |